Hypertonic saline solution for prevention of renal dysfunction in patients with decompensated heart failure

Imagem de Miniatura
Arquivos
art_ISSA_Hypertonic_saline_solution_for_prevention_of_renal_dysfunction_2013.PDF (573.36 KB)
Citações na Scopus
29
Tipo de produção
article
Data de publicação
2013
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER IRELAND LTD
Autores
Citação
INTERNATIONAL JOURNAL OF CARDIOLOGY, v.167, n.1, p.34-40, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Renal dysfunction is associated with increased mortality in patients with decompensated heart failure. However, interventions targeted to prevention in this setting have been disappointing. We investigated the effects of hypertonic saline solution (HSS) for prevention of renal dysfunction in decompensated heart failure. Methods: In a double-blind randomized trial, patients with decompensated heart failure were assigned to receive three-day course of 100 mL HSS (NaCl 7.5%) twice daily or placebo. Primary end point was an increase in serumcreatinine of 0.3 mg/dL or more. Main secondary end point was change in biomarkers of renal function, including serum levels of creatinine, cystatin C, neutrophil gelatinase-associated lipocalin-NGAL and the urinary excretion of aquaporin 2 (AQP(2)), urea transporter (UT-A(1)), and sodium/hydrogen exchanger 3 (NHE3). Results: Twenty-two patients were assigned to HSS and 12 to placebo. Primary end point occurred in two (10%) patients in HSS group and six (50%) in placebo group (relative risk 0.3; 95% CI 0.09-0.98; P=0.01). Relative to baseline, serum creatinine and cystatin C levels were lower in HSS as compared to placebo (P=0.004 and 0.03, respectively). NGAL level was not statistically different between groups, however the urinary expression of AQP2, UT-A1 and NHE3 was significantly higher in HSS than in placebo. Conclusions: HSS administration attenuated heart failure-induced kidney dysfunction as indicated by improvement in both glomerular and tubular defects, a finding with important clinical implications. HSS modulated the expression of tubular proteins involved in regulation of water and electrolyte homeostasis.
Palavras-chave
Heart failure, Renal failure, Renal dysfunction, Hypertonic saline solution, Aquaporin-2
URI
https://observatorio.fm.usp.br/handle/OPI/1713
Referências
  1. Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005
  2. Blair JEA, 2011, EUR HEART J, V32, P2563, DOI 10.1093/eurheartj/ehr238
  3. Bocchi EA, 2009, HEART, V95, P181, DOI 10.1136/hrt.2008.151225
  4. Bocchi EA, 2008, CIRC-HEART FAIL, V1, P115, DOI 10.1161/CIRCHEARTFAILURE.107.744870
  5. Bocchi EA, 2009, ARQ BRAS CARDIOL, V93, P1
  6. Bolignano D, 2008, AM J KIDNEY DIS, V52, P595, DOI 10.1053/j.ajkd.2008.01.020
  7. Centers for Disease Control and Prevention, TITLE ERROR
  8. CRYSTAL GJ, 1994, CIRC SHOCK, V42, P27
  9. Damman K, 2012, HEART FAIL REV, V17, P241, DOI 10.1007/s10741-011-9254-2
  10. Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487
  11. Ding HL, 2007, CLIN IMMUNOL, V123, P227, DOI 10.1016/j.clin.2007.01.010
  12. Feigenbaum MS, 2000, J AM COLL CARDIOL, V35, P51, DOI 10.1016/S0735-1097(99)00530-6
  13. Felker GM, 2011, NEW ENGL J MED, V364, P797, DOI 10.1056/NEJMoa1005419
  14. Funayama H, 2004, KIDNEY INT, V66, P1387, DOI 10.1111/j.1523-1755.2004.00902.x
  15. Gottlieb SS, 2002, J CARD FAIL, V8, P136, DOI 10.1054/jcaf.2002.125289
  16. Grinevich V, 2004, KIDNEY INT, V65, P54, DOI 10.1111/j.1523-1755.2004.00378.x
  17. Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020
  18. Hocherl K, 2010, AM J PHYSIOL-RENAL, V298, pF196, DOI 10.1152/ajprenal.90607.2008
  19. Ing RD, 1994, AM J SURG, V60, P507
  20. Issa VS, 2007, ARQ BRAS CARDIOL, V89, P251, DOI 10.1590/S0066-782X2007001600007
  21. Junger WG, 1997, SHOCK, V8, P235, DOI 10.1097/00024382-199710000-00001
  22. Kalra PR, 2002, J AM COLL CARDIOL, V39, P1901, DOI 10.1016/S0735-1097(02)01903-4
  23. Kien ND, 1989, BRAZ J MED BIOL RES, V22, P2245
  24. Lassus JPE, 2010, EUR HEART J, V31, P2791, DOI 10.1093/eurheartj/ehq293
  25. Lutken SC, 2009, AM J PHYSIOL-RENAL, V297, pF1678, DOI 10.1152/ajprenal.00010.2009
  26. MANINGAS PA, 1987, CRIT CARE MED, V15, P1121, DOI 10.1097/00003246-198712000-00009
  27. Massie BM, 2010, NEW ENGL J MED, V363, P1419, DOI 10.1056/NEJMoa0912613
  28. Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6
  29. Mishra J, 2005, LANCET, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X
  30. Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056
  31. Oliveira RP, 2002, CRIT CARE, V6, P418
  32. Parrinello G, 2011, J CARD FAIL, V17, P331, DOI 10.1016/j.cardfail.2010.11.003
  33. Paterna S, 2005, J AM COLL CARDIOL, V45, P1997, DOI 10.1016/j.jacc.2005.01.059
  34. Penfield WG, 1919, AM J PHYSIOL, V48, P121
  35. RAMIRES JAF, 1992, CIRC SHOCK, V37, P220
  36. Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1
  37. SILVA MRF, 1987, AM J PHYSIOL, V253, pH751
  38. ROCHAESILVA M, 1986, CIRC SHOCK, V19, P165
  39. Thompson R, 2006, J R Army Med Corps, V152, P6
  40. Tuttolomondo A, 2011, NUTR METAB CARDIOVAS, V21, P372, DOI 10.1016/j.numecd.2009.10.014
  41. VELASCO IT, 1980, AM J PHYSIOL, V239, pH664

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - FM/MCP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/11
Artigos e Materiais de Revistas Científicas - LIM/12
Carregar mais